Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSPiRE-ICU2: Inhaled Isoflurane vs Intravenous Propofol for Sedation in ICU
NCT05327296Phase 3Completed
- Sponsor
- Sedana Medical
- Start
- Jun 2022
- Primary completion
- May 2024
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 3 trial of isoflurane in sedation, sponsored by Sedana Medical. Started Jun 2022; status: completed.
02
Drugs
isoflurane
03
Conditions
sedation
Beyond the preview
Go deeper on NCT05327296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05327296.